TEVA Company Profile and Key Details
Teva Pharmaceutical Industries Limited
TEVA Stock Price Chart
Stock Price Today
Teva Pharmaceutical Industries Limited (TEVA) stock declined over -0.46%, trading at $21.82 on NYSE, down from the previous close of $21.92. The stock opened at $22.06, fluctuating between $21.65 and $22.08 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Company Information
| Employees | 37000 |
| Beta | 0.87 |
| Sales or Revenue | $15.85B |
| 5Y Sales Change% | -0.233% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Teva Pharmaceutical Industries Limited (NYSE: TEVA) stock price is $21.82 in the last trading session. During the trading session, TEVA stock reached the peak price of $22.08 while $21.65 was the lowest point it dropped to. The percentage change in TEVA stock occurred in the recent session was -0.46% while the dollar amount for the price change in TEVA stock was -$0.10.
The NYSE listed TEVA is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Teva Pharmaceutical Industries Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
TEVA's closing price is 90.07% higher than its 52-week low of $11.48 where as its distance from 52-week high of $22.80 is -4.3%.
Number of TEVA employees currently stands at 37,000.
Official Website of TEVA is: https://www.tevapharm.com
TEVA could be contacted at phone 972 391 48213 and can also be accessed through its website. TEVA operates from 124 Dvora Hanevi'a Street, Tel Aviv, 6944020, Israel.
TEVA stock volume for the day was 4.92M shares. The average number of TEVA shares traded daily for last 3 months was 9.27M.
The market value of TEVA currently stands at $24.76B with its latest stock price at $21.82 and 1.13B of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com